Medicine

An approach called “rational vaccinology” could allow us to design more powerful vaccines, just by rearranging their ingredients.

A man infected by a deadly brain-eating amoeba is on the road to recovery thanks to a decades-old drug used to treat urinary tract infections.

Researchers find that, in some cases, tooth dentin can be regrown instead of needing to be replaced with man-made composite.

Using a large language model AI, biotech startup Profluent has created new antimicrobial proteins.

Delivering chemotherapy to colon cancer patients before and after surgery — instead of just after — reduces their risk of recurrence by 28%.

Using spiraling ultrasound waves, researchers hope to remove stroke-causing blood clots faster and safer.

A microbiome-friendly method of controlling Staph colonization has aced phase 2 clinical trials.

Alto Neuroscience’s depression drug seems effective in early trials, a proof-of-concept for biomarker-based design.

BioNTech is sending a modular mRNA vaccine factory that can produce 50 million COVID-19 vaccines annually to Africa.

Moderna’s mRNA RSV vaccine for adults looks to be over 80% effective, based on early data from a large phase 3 trial.